184 related articles for article (PubMed ID: 38265560)
1. Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes.
Schmidt J; Kaulfuß S; Ott H; Gaubert M; Reintjes N; Bremmer F; Dreha-Kulaczewski S; Stroebel P; Yigit G; Wollnik B
Hum Genet; 2024 Feb; 143(2):159-168. PubMed ID: 38265560
[TBL] [Abstract][Full Text] [Related]
2. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
3. Mosaic-activating FGFR2 mutation in two fetuses with papillomatous pedunculated sebaceous naevus.
Kuentz P; Fraitag S; Gonzales M; Dhombres F; St-Onge J; Duffourd Y; Joyé N; Jouannic JM; Picard A; Marle N; Thevenon J; Thauvin-Robinet C; Faivre L; Rivière JB; Vabres P
Br J Dermatol; 2017 Jan; 176(1):204-208. PubMed ID: 27095246
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
5. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
[TBL] [Abstract][Full Text] [Related]
6. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
[TBL] [Abstract][Full Text] [Related]
7. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
8. Schimmelpenning-Feuerstein-Mims syndrome with orbital choristoma and
Yeager LB; Casper DS; Del Portillo A; Marr BP
Ophthalmic Genet; 2023 Dec; ():1-6. PubMed ID: 38097938
[TBL] [Abstract][Full Text] [Related]
9. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
10. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
[TBL] [Abstract][Full Text] [Related]
11. Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.
Bennett JT; Tan TY; Alcantara D; Tétrault M; Timms AE; Jensen D; Collins S; Nowaczyk MJM; Lindhurst MJ; Christensen KM; Braddock SR; Brandling-Bennett H; Hennekam RCM; Chung B; Lehman A; Su J; Ng S; Amor DJ; ; ; Majewski J; Biesecker LG; Boycott KM; Dobyns WB; O'Driscoll M; Moog U; McDonell LM
Am J Hum Genet; 2016 Mar; 98(3):579-587. PubMed ID: 26942290
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome.
Lajeunie E; Heuertz S; El Ghouzzi V; Martinovic J; Renier D; Le Merrer M; Bonaventure J
Eur J Hum Genet; 2006 Mar; 14(3):289-98. PubMed ID: 16418739
[TBL] [Abstract][Full Text] [Related]
13. A de novo missense mutation of FGFR2 causes facial dysplasia syndrome in Holstein cattle.
Agerholm JS; McEvoy FJ; Heegaard S; Charlier C; Jagannathan V; Drögemüller C
BMC Genet; 2017 Aug; 18(1):74. PubMed ID: 28768473
[TBL] [Abstract][Full Text] [Related]
14. Somatic KRAS mutation in an infant with linear nevus sebaceous syndrome associated with lymphatic malformations: A case report and literature review.
Lihua J; Feng G; Shanshan M; Jialu X; Kewen J
Medicine (Baltimore); 2017 Nov; 96(47):e8016. PubMed ID: 29381910
[TBL] [Abstract][Full Text] [Related]
15. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
16. Identification of a recurrent mosaic
Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
[TBL] [Abstract][Full Text] [Related]
17. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
Mitchell BJ; Rogers GF; Wood BC
J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
[TBL] [Abstract][Full Text] [Related]
18. Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations.
Theiler M; Weibel L; Christen-Zaech S; Carmignac V; Sorlin A; Neuhaus K; Chevarin M; Thauvin-Robinet C; Philippe C; Faivre L; Vabres P; Kuentz P
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2085-2090. PubMed ID: 33930231
[TBL] [Abstract][Full Text] [Related]
19. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.
Galvin BD; Hart KC; Meyer AN; Webster MK; Donoghue DJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7894-9. PubMed ID: 8755573
[TBL] [Abstract][Full Text] [Related]
20. Novel mutation detection in craniosynostosis promotes characterization, identification, gene expression, tissue engineering and helps clinical practice and translational research.
Barik M; Bano R; Bajpai M; Tripathy M; Das S; Dwivedi S
Neurol India; 2020; 68(2):435-439. PubMed ID: 32415020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
